NeurologyLive Friday 5 — October 23, 2020

October 23, 2020
NeurologyLive Staff

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 23, 2020.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Podcast: Taking Steps to Advance Sleep Care

Episode 20 of "Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Raman Malhotra, MD, on the current state of sleep medicine and what's to come in the near future.

2: Advanced Imaging for Extended Stroke Treatment

With many patients presenting with an unknown time of last known well, G. Abbas Kharal, MD, MPH; Emmanuel C. Obusez, MD; and M. Shazam Hussain, MD, FRCP(C), FAHA explore establishing a tissue window using advanced imaging techniques may allow for more effective intervention and better outcomes.

3: Pavel Klein, MD: Telemedicine Impact on Patient-Clinician Relationship

The director of the Mid-Atlantic Epilepsy and Sleep Center in Bethesda, Maryland, shared his thoughts on how technology has affected patient care and the patient-physician dynamic during the COVID-19 pandemic.

4: Building Your Acute Migraine Toolbox

Plagued by a long history of under- and inadequate treatment, Duren M. Ready, MD, FAHS, and Evelyn Sbar, MD, describe how clinicians now have more options than ever to craft a personalized, effective plan for their patients.

5: Rapid Readout: OLKIOS – Looking at Ofatumumab’s Continued Efficacy

Mark Freedman, MD, highlights the OLKIOS phase 3b study evaluating ofatumumab’s continued efficacy in patients previously treated with traditional anti-CD20 therapy, as well as concerns about switching from a humanized anti-CD20 monoclonal antibody to a fully human monoclonal antibody.